On 7 April 2017 Ambaw Bellete - Head, US Cancer Commercial 
Operations - purchased 2,000 Photocure shares at a price of 
NOK 30.13 each.

Ambaw Bellete now holds 2,000 shares and 76,600 options in 
Photocure.

This notification is made pursuant to the Norwegian 
Securities Trading Act sections 4-2.
